APO PIROXICAM CAP 20MG 20 MG
PIROXICAM : 20 MG · DIN 00642894 · APOTEX INC
Health Canada status: MARKETED
What is APO PIROXICAM CAP 20MG?
APO PIROXICAM CAP 20MG 20 MG contains PIROXICAM : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 00642894, held by APOTEX INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Dec-1986. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00642894 |
|---|---|
| Brand name | APO PIROXICAM CAP 20MG |
| Generic / active ingredient | PIROXICAM : 20 MG |
| Manufacturer | APOTEX INC |
| Strength | 20 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M01AC01 PIROXICAM |
| AHFS class | 28:08.04.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1986 |
| Original market date | 1986-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code M01AC01 PIROXICAM. 4 of 32 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO PIROXICAM CAP 10MG | 10 MG | CAPSULE | APOTEX INC | MARKETED | DIN 00642886 |
| TEVA-PIROXICAM | 10 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 00695718 |
| TEVA-PIROXICAM | 20 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 00695696 |
| ALTI-PIROXICAM-CAP 10MG | 10 MG | CAPSULE | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02139952 |
| ALTI-PIROXICAM-CAP 20MG | 20 MG | CAPSULE | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02139960 |
| BREXIDOL 20 | 191.2 MG | TABLET | CHIESI FARMACEUTICI S.P.A. | CANCELLED POST MARKET | DIN 02239599 |
| DOM-PIROXICAM | 10 MG | SUPPOSITORY | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02177129 |
| DOM-PIROXICAM | 10 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02239922 |
| DOM-PIROXICAM | 20 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02239536 |
| DOM-PIROXICAM | 20 MG | SUPPOSITORY | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02177137 |
Who else supplies PIROXICAM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PIROXICAM appears in 740 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.